{
    "nctId": "NCT06104085",
    "briefTitle": "99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer",
    "officialTitle": "99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "semi-quantitative analysis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female, aged between 18 and 80 years old.\n* Patients with suspected or definite diagnosis of triple-negative breast cancer.\n* Patients with suspected or confirmed triple-negative recurrent or metastatic breast cancer.\n* Female subjects must have medical records to prove that they have undergone surgical sterilization (such as hysterectomy, bilateral oophorectomy, or tubal ligation) or have been menopausal for more than one year; if they still have the ability to conceive, isolation contraceptive measures must be taken during this study period.\n\nExclusion Criteria:\n\n* Suffering from severe gastrointestinal, cardiovascular, liver, kidney, blood system, endocrine, respiratory system, immune deficiency and other serious diseases.\n* Claustrophobia.\n* In the past year, due to other clinical medical treatment or scientific research needs, received ionizing radiation outside the scope of this experiment, so that the annual radiation exposure dose exceeded 50mSv.\n* Pregnant or lactating women.\n* Received experimental drug or device treatment (with unclear efficacy or safety) within 1 month.\n* There is any situation in which the conductor of this study believes that any aspect related to this experiment may cause harm or be potentially harmful.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}